Advertisement

Resilience Strategies and the Pharmaceutical Supply Chain: The Role of Agility in Mitigating Drug Shortages

  • Emilia Vann YarosonEmail author
  • Liz Breen
  • Jiachen Hou
  • Julie Sowter
Chapter
Part of the Lecture Notes in Logistics book series (LNLO)

Abstract

Supply chain resilience has been suggested to curb the impact of disruptions on supply chains. While this proposition seems coherent in theory, empirical evidence supporting this is limited, as existing literature has centred on exploring the impact of supply chain resilience on disruptions which are based on set time frames, non-supply chain specific as well as examining non-dynamic disruptive events. This study contends that resilience strategies are dynamic and as such their applications within supply chains differ. Therefore examining the impact of resilience will be appropriate on a dynamic disruption within a specific supply chain. In view of this, the paper examines through existing literature the applicability of agility within the pharmaceutical supply chain when dynamic disruptions like drug shortages occur. The study finds alertness, accessibility, connectivity and visibility as dimensions of supply chain agility that are capable of reducing the impact of drug shortages.

References

  1. Ambulkar, S., Blackhurst, J., & Grawe, S. (2015). Firm’s resilience to supply chain disruptions: Scale development and empirical examination. Journal of Operations Management, 33, 111–122.CrossRefGoogle Scholar
  2. Barratt, M. (2004). Understanding the meaning of collaboration in the supply chain. Supply Chain Management: An International Journal, 9(1), 30–42.Google Scholar
  3. Barratt, M., & Oke, A. (2007). Antecedents of supply chain visibility in retail supply chains: A resource-based theory perspective. Journal of Operations Management, 25(6), 1217–1233.CrossRefGoogle Scholar
  4. Bogaert, P., Bochenek, T., Prokop, A., & Pilc, A. (2015). A qualitative approach to a better understanding of the problems underlying drug shortages, as viewed from Belgian, French and the European Union’s perspectives. PLoS ONE, 10(5), e0125691.CrossRefGoogle Scholar
  5. Brandon‐Jones, E., Squire, B., Autry, C. W., & Petersen, K. J. (2014). A contingent resource‐based perspective of supply chain resilience and robustness. Journal of Supply Chain Management, 50(3), 55–73.Google Scholar
  6. Braunscheidel, M. J., & Suresh, N. C. (2009). The organizational antecedents of a firm’s supply chain agility for risk mitigation and response. Journal of Operations Management, 27(2), 119–140.CrossRefGoogle Scholar
  7. Breen, L., & Yaroson, E. (2018). Medicine shortages are already a reality but a no deal Brexit could make it worse, The conversion. https://theconversation.com/medicine-shortages-are-already-a-reality-but-a-no-deal-brexit-could-make-it-worse-102218
  8. Christopher, M. (2000). The agile supply chain: Competing in volatile markets. Industrial Marketing Management, 29(1), 37–44.CrossRefGoogle Scholar
  9. Christopher, M., & Peck, H. (2004). Building the resilient supply chain. The International Journal of Logistics Management, 15(2), 1–14.CrossRefGoogle Scholar
  10. De Weerdt, E., Simoens, S., Hombroeckx, L., Casteels, M., & Huys, I. (2015). Causes of drug shortages in the legal pharmaceutical framework. Regulatory Toxicology and Pharmacology, 71(2), 251–258.CrossRefGoogle Scholar
  11. Dubey, R., Altay, N., Gunasekaran, A., Blome, C., Papadopoulos, T., & Childe, S. J. (2018). Supply chain agility, adaptability and alignment: Empirical evidence from the Indian auto components industry. International Journal of Operations & Production Management, 38(1), 129–148.CrossRefGoogle Scholar
  12. Fawcett, S. E., McCarter, M. W., Fawcett, A. M., Webb, G. S., & Magnan, G. M. (2015). Why supply chain collaboration fails: The socio-structural view of resistance to relational strategies. Supply Chain Management: An International Journal, 20(6), 648–663.Google Scholar
  13. Fox, E. R., Sweet, B. V., Jensen, V. (2014, March). Drug shortages: A complex health care crisis. In Mayo Clinic Proceedings, 89(3), 361–373. Elsevier.Google Scholar
  14. Heiskanen, K., Ahonen, R., Kanerva, R., Karttunen, P., & Timonen, J. (2017). The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. PloS one, 12(6), e0179479.Google Scholar
  15. Jüttner, U., & Maklan, S. (2011). Supply chain resilience in the global financial crisis: An empirical study. Supply Chain Management: An International Journal, 16(4), 246–259.CrossRefGoogle Scholar
  16. Kumar, S., Liu, J., & Scutella, J. (2015). The impact of supply chain disruptions on stockholder wealth in India. International Journal of Physical Distribution & Logistics Management, 45(9/10), 938–958.CrossRefGoogle Scholar
  17. Kweder, S. L., & Dill, S. (2013). Drug shortages: The cycle of quantity and quality. Clinical Pharmacology and Therapeutics, 93(3), 245–251.CrossRefGoogle Scholar
  18. Lücker, F., & Seifert, R. W. (2017). Building up resilience in a pharmaceutical supply chain through inventory, dual sourcing and agility capacity. Omega, 73, 114–124.CrossRefGoogle Scholar
  19. Naylor, J. B., Naim, M. M., & Berry, D. (1999). Leagility: Integrating the lean and agile manufacturing paradigms in the total supply chain. International Journal of Production Economics, 62(1–2), 107–118.Google Scholar
  20. Ponomarov, S. Y., & Holcomb, M. C. (2009). Understanding the concept of supply chain resilience. The International Journal of Logistics Management, 20(1), 124–143.CrossRefGoogle Scholar
  21. Swink, M., & Schoenherr, T. (2015). The effects of cross‐functional integration on profitability, process efficiency, and asset productivity. Journal of Business Logistics, 36(1), 69–87.Google Scholar
  22. Trkman, P., & McCormack, K. (2009). Supply chain risk in turbulent environments—A conceptual model for managing supply chain network risk. International Journal of Production Economics, 119(2), 247–258.CrossRefGoogle Scholar
  23. Tukamuhabwa, B. R., Stevenson, M., Busby, J., & Zorzini, M. (2015). Supply chain resilience: Definition, review and theoretical foundations for further study. International Journal of Production Research, 53(18), 5592–5623.CrossRefGoogle Scholar
  24. Ventola, C. L. (2011). The drug shortage crisis in the United States: Causes, impact, and management strategies. Pharmacy and Therapeutics, 36(11), 740.Google Scholar
  25. Wieland, A., & Marcus Wallenburg, C. (2013). The influence of relational competencies on supply chain resilience: A relational view. International Journal of Physical Distribution & Logistics Management, 43(4), 300–320.CrossRefGoogle Scholar
  26. Williams, B. D., Roh, J., Tokar, T., & Swink, M. (2013). Leveraging supply chain visibility for responsiveness: The moderating role of internal integration. Journal of Operations Management, 31(7–8), 543–554.CrossRefGoogle Scholar
  27. Zhao, X., Huo, B., Selen, W., & Yeung, J. H. Y. (2011). The impact of internal integration and relationship commitment on external integration. Journal of Operations Management, 29(1–2), 17–32.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Emilia Vann Yaroson
    • 1
    Email author
  • Liz Breen
    • 2
  • Jiachen Hou
    • 1
  • Julie Sowter
    • 2
  1. 1.School of ManagementUniversity of BradfordBradfordUK
  2. 2.School of Pharmacy and Medical SciencesUniversity of BradfordBradfordUK

Personalised recommendations